A COVID-19 antibody cocktail developed by the US-based company, Regeneron, dramatically reduced the risk of mortality and shortened hospital stays in patients who didn’t naturally produce antibodies against SARS-CoV2 in a recent large-scale trial.  Meanwhile, the US government announced that it would invest some US$3.2 billion in developing new forms of antiviral COVID-19 treatments to […] Continue reading ->
In a “groundbreaking” trial conducted in Indonesia, lab-grown mosquitoes infected with Wolbachia bacteria reduced the rate of symptomatic dengue infections by 77%, and hospitalizations by 86%, in communities where the bacteria-armed mosquitoes were released.   The three-year study, which was led by the World Mosquito Program, provides compelling evidence for a new method of controlling dengue. […] Continue reading ->
Providing community-based mental health care that is respectful of human rights and recovery-focused has proven successful and cost-effective, according to a new report released by the World Health Organization.  WHO’s new “Guidance on community mental health service: promoting person-centered and rights-based approaches”, released today, includes examples from countries including Brazil, India, Kenya, Myanmar, New Zealand, […] Continue reading ->
Researchers engaged in mosquito gene drive technologies are optimistic that new World Health Organization (WHO) guidance on best research practices will ensure that their work is safe and ethical. Such guidance also helps research results advance from laboratories to be used in the field,  the researchers told Health Policy Watch. Due to limiting regulatory frameworks, […] Continue reading ->